Clinical pharmacology of an etorphine-acepromazine preparation: experiments in dogs and horses.
D000075:Acepromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000662:veterinary; D003521:Cyclopropanes / Q000494:pharmacology; D004283:Dog Diseases / Q000139:chemically induced; D004285:Dogs; D004338:Drug Combinations; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006734:Horse Diseases / Q000139:chemically induced; D006736:Horses; D006973:Hypertension / Q000662:veterinary; D007022:Hypotension / Q000662:veterinary; D007275:Injections, Intravenous; D008297:Male; D009019:Morphinans / Q000008:administration & dosage / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology; D009458:Neuroleptanalgesia; D012119:Respiration / Q000187:drug effects; D014202:Tremor / Q000662:veterinary; D014628:Vagotomy; D014690:Venous Pressure / Q000187:drug effects
D000700:Analgesics; D003521:Cyclopropanes; D004338:Drug Combinations; D009019:Morphinans; D009292:Narcotic Antagonists; D000075:Acepromazine